Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients
Status:
Completed
Trial end date:
2020-10-14
Target enrollment:
Participant gender:
Summary
A randomized controlled trial on using Ivermectin and doxycycline to treat mild-moderate
outpatients, severe, and critical inpatients of Coronavirus disease 19 (COVID-19) along with
standard of care. Seventy Iraqi COVID-19 patients received Ivermectin and Doxycycline plus
standard of care versus seventy Iraqi COVID-19 patients received standard of care only. .